DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Fassnacht M, Berruti A, Baudin E. et al.
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.
Lancet Oncol 2015;
16: 426-435
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.